AstrinGyn — Class II drug recall D-1101-2023
Completed recall by Ecometics, Inc., reported 2023-08-30, distributed nationwide. CGMP Deviations: Products not manufactured under current good manufacturing practices.
| Recall number | D-1101-2023 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Completed |
| Voluntary or mandated | Voluntary |
| Recalling firm | Ecometics, Inc., Norwalk, CT, United States |
| Recall initiated | 2023-08-09 |
| Classified | 2023-08-24 |
| Reported by FDA | 2023-08-30 |
| Distributed | Nationwide (US) |
| Quantity | 92,967 vials |
| Reason classes | cgmp |
| NDC | 59365-6065-00 |
| Lot numbers | 2E144A, 2E157A, 2E270A, 2E300A |
| Model numbers | 6065 |
| Expiration dates | 2023-11, 2024-03, 2024-04 |
Product
AstrinGyn (Ferric Subsulfate) Aqueous, 259 mg/g, 8 gm Single Use Vials, Manufactured for CooperSurgical, Trumbull, CT 06611, NDC 59365-6065-0, Ref 6065.
Reason for recall
CGMP Deviations: Products not manufactured under current good manufacturing practices.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1101-2023. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.